An Investigational Study of Continuous 8-Hour Intravenous Administrations of BMS-986231 in Participants With Heart Failure and Reduced Heart Function Given a Standard Dose of Loop Diuretic

NCT03730961 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

23

Enrollment

INDUSTRY

Sponsor class

Conditions

Cardiac Failure
Myocardial Failure
Congestive Heart Failure
Heart Decompensation

Interventions

DRUG: BMS-986231
DRUG: Furosemide
DRUG: Placebo

Sponsor

Bristol-Myers Squibb